scholarly journals The Novel Organic Arsenical Darinaparsin Induces MAPK-Mediated and SHP1-Dependent Cell Death in T-cell Lymphoma and Hodgkin Lymphoma Cells and Human Xenograft Models

2014 ◽  
Vol 20 (23) ◽  
pp. 6023-6033 ◽  
Author(s):  
Dashnamoorthy Ravi ◽  
Savita Bhalla ◽  
Ronald B. Gartenhaus ◽  
Jennifer Crombie ◽  
Irawati Kandela ◽  
...  
2019 ◽  
Vol 143 (1) ◽  
pp. 78-88 ◽  
Author(s):  
Hamidah Muhamad ◽  
Narittee Suksawai ◽  
Thamatorn Assanasen ◽  
Chantana Polprasert ◽  
Udomsak Bunworasate ◽  
...  

The programmed cell death 1/programmed cell death ligands (PD-1/PD-Ls) axis is a potential immune escape mechanism of cancers. However, data on the PD-1/PD-Ls pathway in EBV-associated extranodal natural killer/T cell lymphoma (ENKTL) and its clinical implication are limited. Herein, we characterized PD-1/PD-L expression and its prognosis relevance in 49 ENKTL patients in Thailand. PD-L1 was expressed frequently on both lymphoma cells (61.2%) and stroma (77.5%), whereas PD-L2 expression was more common on lymphoma (63.2%) than stromal cells. PD-1 was positive in 20.5% of stroma, but undetectable on lymphoma cells. There was no association between baseline clinical characteristics and the expression PD-1/PD-Ls. The survival of patients with PD-Ls on tumor cells was poor. For PD-L1-positive versus negative cases, the 2-year event-free survival (EFS) was 42.2 versus 71.8% (p = 0.03) and 2-year overall survival (OS) was 45.4 versus 78.9% (p = 0.02), respectively. Comparing between patients with PD-L2-positive and PD-L2-negative lymphoma, the 2-year EFS was 37.1 versus 82.4% (p = 0.02) and 2-year OS was 45.2 versus 82.4% (p = 0.03), respectively. Neither PD-1 nor PD-Ls expression in the stroma predicted outcomes. In conclusion, PD-Ls were frequently expressed on ENKTL cells and associated with inferior outcomes. Therefore, PD-Ls are potential prognostic biomarkers and the roles of immune checkpoint blockade therapy in ENKTL deserve further investigation.


2012 ◽  
Vol 36 (3) ◽  
pp. 350-357 ◽  
Author(s):  
Areumnuri Kim ◽  
Jung-Eun Lee ◽  
Won-Suk Jang ◽  
Sun-Joo Lee ◽  
Sunhoo Park ◽  
...  

2018 ◽  
Vol 11 (1) ◽  
pp. 29-32 ◽  
Author(s):  
Taku Fujimura ◽  
Kayo Tanita ◽  
Yota Sato ◽  
Yumi Kambayashi ◽  
Sadanori Furudate ◽  
...  

Mogamulizumab induces cytotoxicity against CCR4+ lymphoma cells by antibody-dependent cell-mediated cytotoxicity in advanced cutaneous T-cell lymphoma patients. Since the efficacy of mogamulizumab in mycosis fungoides (28.6%) is lower than that in Sézary syndrome (47.1%), reagents that enhance the antitumor immune response induced by mogamulizumab are needed to further optimize its use for the treatment of erythrodermic mycosis fungoides. In this report, we present a case of erythrodermic mycosis fungoides successfully treated with mogamulizumab followed by etoposide monotherapy.


2009 ◽  
Vol 69 (6) ◽  
pp. 2365-2374 ◽  
Author(s):  
Michael K. Kiessling ◽  
Claus D. Klemke ◽  
Marcin M. Kamiński ◽  
Ioanna E. Galani ◽  
Peter H. Krammer ◽  
...  

1998 ◽  
Vol 5 (11) ◽  
pp. 973-983 ◽  
Author(s):  
Hiroshi Adachi ◽  
Anthony Adams ◽  
Francis M Hughes ◽  
Jiandi Zhang ◽  
John A Cidlowski ◽  
...  

Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 4828-4828 ◽  
Author(s):  
Klara R. Klein ◽  
Casey S. Woodward ◽  
Edmund K. Waller ◽  
Mary Jo Lechowicz ◽  
Hilary Rosenthal

Abstract Background: T cell lymphoma, comprising 15% of diagnosed US lymphomas, currently has no standard of care in the relapsed setting. Exposure to molds diminishes the numbers of T-helpers cells in peripheral blood. Aspergillus and Penicillium are known to produce small molecules called mycotoxins. Mycotoxins have previously been associated with immunosuppressive effects (Sutton et al., 1994, 1995), and a reduction of cytokine secretion (Rossano et al., 1999.) This study investigates the effects of two of these mycotoxins, Gliotoxin and Patulin, on the cellular components of mononuclear cells in peripheral blood of normal donors and T-cell lymphoma cells, examining viability and apoptotic damage in CD3+ (T cells), CD4+ (cytotoxic t cells), CD8+ (t helper cells), and CD16+ (NK cells), BDCA1+ and BDCA2+ (dendritic cells), CD14+ (monocytes), and CD19+ (B cells). Methods: Two mycotoxins, Gliotoxin and Patulin were solubilized into methanol or ethanol and cultured with either normal ficolled blood samples, T-cell lymphoma or T-cell leukemic cells. We plated cells at a concentration of 1x 106 cells per well, treated them with concentrations of 0, 1, 10, 100, 1,000, or 10,000 ng/mL, and incubated for 24 hours. After incubation the cells were removed and washed, and stained with fluorescent antibodies. Cellular content was determined by flow cytometry (FACS). Prior to acquisition by FACS, counting beads were added to each sample to determine absolute counts of each population of cells. Populations of interest were CD3+, CD4+, CD8+, and CD16+, BDCA1+ and BDCA2+, CD14+, and CD19+. Annexin and Propidium Iodide (PI) were added to evaluate apoptotic and non-viable cells. FloJo software was used to analyze the FACS data. Absolute count of viable cells was then converted to percentages using solvent only control as 100% viable. Results: Cell Viability after 24 hr Incubation with Mycotoxins Concentration Normal Peripheral Blood (n=9) T Cell Lymphoma (n=2) Gliotoxin (ng/mL) CD3+/CD4+ CD3+/CD8+ DC1 DC2 NK B CD3+ Median Percent Viable when 0 ng/mL = 100% Viable 0 100 100 100 100 100 100 100 1 127 128 219 143 104 127 96 10 126 129 36 69 109 117 82 100 15 15 3 25 2 18 110 1,000 23 33 3 11 13 11 37 10,000 47 46 63 13 26 27 4 Patulin (ng/mL) 0 100 100 100 100 100 100 100 1 66 68 74 86 60 81 93 10 94 100 101 114 84 88 333 100 84 101 79 141 110 138 152 1,000 39 38 2 26 35 27 69 10,000 53 45 0 34 39 78 1 The dose of Gliotoxin, most effective for inducing apoptosis and cell death in normal donor T cells is 100 ng/mL, whereas the most effective dose of Patulin was 1,000 ng/mL. In the cell line, the lowest dose of both mycotoxins that produced significant apoptosis and cell death was 1,000 ng/mL. Conclusion: Our results demonstrate that the mycotoxins, Patulin and Gliotoxin kill PBMC, and confirm the results found by Stanzani et al that Gliotoxin is most cytotoxic against the antigen presenting cells (APC), which impairs T cell response. Our experiment showed that Patulin had the same effect against APC. T cell viability itself was greatly influenced by the addition of Gliotoxin or Patulin, which supports previous evidence that mycotoxins suppress some populations of T cells. Certain issues, such as a less toxic solvent must be addressed; the data, however, shows that mycotoxins do have the ability to kill both normal and T cell leukemic/lymphoma cells.


Sign in / Sign up

Export Citation Format

Share Document